Még nem toboroz
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
NCT07919405· 3. fázis· Novo Nordisk A/S· Forrás
Contact: Novo Nordisk
Toboroz
FT839 in Autoimmune Diseases
NCT07800871· 1/2. fázis· Fate Therapeutics· Forrás
Contact: Fate Clinical Trials
Toboroz
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
NCT07720271· 3. fázis· Novo Nordisk A/S· Forrás
Contact: Novo Nordisk
Toboroz
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
NCT07570862· 2. fázis· Fate Therapeutics· Forrás
Contact: Fate Clinical Trials
Toboroz
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849· 3. fázis· Incyte Corporation· Forrás
Toboroz
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298· 1/2. fázis· Pfizer· Forrás
Toboroz
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
NCT06745908· 3. fázis· ImmunityBio, Inc.· Forrás
Contact: Yebin Kwon
Toboroz
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
NCT07144280· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
NCT07076199· 3. fázis· Novo Nordisk A/S· Forrás
Toboroz
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634· 3. fázis· Celcuity Inc· Forrás
Contact: Nadene Zack, MS
Toboroz
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401· 3. fázis· Pfizer· Forrás
Toboroz
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
NCT06875310· 3. fázis· Mirati Therapeutics Inc.· Forrás
Contact: David Park, Site 0581
Toboroz
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
NCT06644781· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
NCT06806033· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
NCT06760637· 3. fázis· Pfizer· Forrás
Toboroz
A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
NCT06747585· 1/2. fázis· Alentis Therapeutics AG· Forrás
Toboroz
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
NCT06246916· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
NCT06061809· 2. fázis· ImmunityBio, Inc.· Forrás
Fut, nem toboroz
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
NCT06293365· 2. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
NCT06425926· 1/2. fázis· Georgiamune Inc· Forrás
Contact: Kendall Karp
Fut, nem toboroz
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
NCT06235151· 3. fázis· Curium US LLC· Forrás
Toboroz
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
NCT06308978· 1. fázis· Fate Therapeutics· Forrás
Contact: Fate Clinical Trials
Fut, nem toboroz
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
NCT06012435· 3. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás
Toboroz
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
NCT06072482· 4. fázis· Amgen· Forrás
Fut, nem toboroz
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
NCT06005740· 1. fázis· TORL Biotherapeutics, LLC· Forrás
Fut, nem toboroz
A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
NCT05985915· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
First in Human Study of TORL-3-600 in Participants With Advanced Cancer
NCT05948826· 1. fázis· TORL Biotherapeutics, LLC· Forrás
Fut, nem toboroz
To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
NCT05468489· 2. fázis· Shanghai Henlius Biotech· Forrás
Toboroz
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
NCT05386108· 1/2. fázis· Stemline Therapeutics, Inc.· Forrás
Contact: Monica Lee (principal investigator)
Toboroz
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171· 2/3. fázis· Panbela Therapeutics, Inc.· Forrás
Contact: Jagruti Khandhadia
Fut, nem toboroz
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
NCT05349214· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
NCT05288166· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
NCT05169567· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
NCT05204927· 3. fázis· Curium US LLC· Forrás
Toboroz
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
NCT05098132· 1/2. fázis· Synthekine· Forrás
Fut, nem toboroz
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
NCT05163028· 1. fázis· HUYABIO International, LLC.· Forrás
Toboroz
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
NCT05103683· 1. fázis· TORL Biotherapeutics, LLC· Forrás
Contact: Yung Lyou, MD
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus
NCT04963296· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632· 1. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás